| 摘要 |
The present invention relates to pharmaceutical formulations for the prophylactic treatment of peanut allergy and the use thereof in such as treatment such as immunotherapy or immunovaccination. Specifically, the present invention relates to pharmaceutical compositions comprising a modified whole peanut extract and pharmaceutically acceptable diluents and/or excipients, wherein said modified whole peanut extract is a reduced and subsequently alkylated whole peanut extract, preferably a whole defatted peanut extract comprising soluble peanut kernel proteins such as Ara hi, Ara h2 and Ara h6. |
